new tirzepatide drug Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study Tirzepatide Wins FDA Approval for

A phase 2 study reported clinically meaningful improvements in blood sugar control and strong reductions in body weight, which adds to the interest around its future potential in metabolic disease research

Sustained fat loss accelerates in weeks 2-4 as appetite suppression deepens

Genetic predisposition testing can support these conversations with providers about personalization factors

Another concern is side effects

Many patients find that eating smaller, more frequent meals, staying well hydrated, and avoiding very fatty or rich foods helps manage any nausea or digestive discomfort during the adjustment period

Undefeated in trial and complex product liability litigation National reach with a personal, boutique-level focus Contingency fee structure: no payment unless we win Over 50 years of compained eperience holding multi-national companies accountable We dont just build cases, we build leverage